Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China flag China · Delayed Price · Currency is CNY
23.24
+0.29 (1.26%)
Apr 30, 2026, 3:00 PM CST

SHA:605033 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,1422,7151,6262,4272,3593,611
Market Cap Growth
29.83%66.92%-32.98%2.88%-34.67%-
Enterprise Value
2,5292,2221,1762,1262,0603,339
Last Close Price
23.2420.0811.9417.5416.5325.60
PE Ratio
64.5655.7944.1342.1616.2628.72
PS Ratio
3.452.981.843.472.604.29
PB Ratio
2.732.351.452.182.173.74
P/TBV Ratio
3.032.621.622.352.203.77
P/FCF Ratio
70.2460.6913.3818.51137.78-
P/OCF Ratio
13.7011.845.807.2518.66-
EV/Sales Ratio
2.772.441.333.042.273.96
EV/EBITDA Ratio
25.9522.8029.9333.3413.7324.63
EV/EBIT Ratio
39.0334.2962.3149.5615.3127.13
EV/FCF Ratio
56.5249.669.6716.22120.32-
Debt / Equity Ratio
0.130.130.070.00-0.03
Debt / EBITDA Ratio
1.551.551.860.02-0.20
Debt / FCF Ratio
3.373.370.600.01--
Net Debt / Equity Ratio
-0.53-0.53-0.52-0.43-0.37-0.39
Net Debt / EBITDA Ratio
-6.30-6.30-14.84-7.53-2.66-2.77
Net Debt / FCF Ratio
-13.71-13.71-4.80-3.66-23.341.74
Asset Turnover
0.460.460.500.430.600.75
Inventory Turnover
2.412.412.121.181.041.27
Quick Ratio
1.171.171.211.391.691.14
Current Ratio
1.641.641.782.333.212.73
Return on Equity (ROE)
4.27%4.27%3.29%5.23%14.13%17.76%
Return on Assets (ROA)
2.06%2.06%0.66%1.65%5.56%6.84%
Return on Invested Capital (ROIC)
10.09%11.14%3.13%5.99%20.05%25.66%
Return on Capital Employed (ROCE)
4.80%4.80%1.50%3.50%11.30%12.00%
Earnings Yield
1.55%1.79%2.27%2.37%6.15%3.48%
FCF Yield
1.42%1.65%7.48%5.40%0.73%-5.96%
Dividend Yield
0.65%-1.21%0.85%1.33%0.74%
Payout Ratio
49.51%49.51%76.62%51.82%18.38%2.62%
Buyback Yield / Dilution
0.98%0.98%-1.99%1.29%-22.93%-9.27%
Total Shareholder Return
1.62%0.98%-0.78%2.14%-21.60%-8.53%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.